Bioinformatics analysis reveals the key factors affecting the progress of osteoporosis

Hao Huang; Wenhao Tang; Chengliang Yang

doi:10.62051/ijphmr.v1n1.12

Authors

Hao Huang
Wenhao Tang
Chengliang Yang

DOI:

https://doi.org/10.62051/ijphmr.v1n1.12

Keywords:

Osteoporosis, Bioinformatics, Markers, MiRNA

Abstract

The incidence rate of osteoporosis is high, and patients usually have decreased bone density and increased risk of fracture, which seriously affects their quality of life. This study aims to reveal key biomarkers that affect the progression of osteoporosis through bioinformatics methods. This study selected the GSE91033 and GSE93883 datasets for analysis, and obtained differentially expressed miRNAs using the GEO2R analysis tool; Predicting potential miRNA target factors through miRDIP and conducting pathway enrichment analysis of target factors through DAVID database; Analyze the interaction relationships between target factors through the STRING database, and construct a protein interaction network and a miRNA mRNA interaction network. The results showed that 73 and 79 differentially expressed genes were obtained in the GSE91033 and GSE93883 datasets, respectively. Common genes included hsa-miR-4508, hsa-miR-660-5p, and hsa-miR-424-5p. Pathway enrichment analysis showed that downstream target factors of differentially expressed miRNAs involved PIK/AKT, Wnt, Hippo, MAPK, and NF-κB pathway is closely related to cell proliferation and differentiation, and also involves intracellular phosphorylation activity. Protein interaction analysis revealed that CCND1, WEE1, MAP2K1, BTRC, FGF2, AXIN2, PTCH1, CCND2, KIF5C, DYNC1I1 and PAFAH1B1 are node genes involved in the progression of osteoporosis. The miRNA mRNA interaction network revealed that hsa-miR-424-5p is a key factor affecting the progression of osteoporosis.

References

BEHERA J, ISON J, VOOR M J, et al. Exercise-Linked Skeletal Irisin Ameliorates Diabetes-Associated Osteoporosis by Inhibiting the Oxidative Damage-Dependent miR-150-FNDC5/Pyroptosis Axis [J]. Diabetes, 2022, 71(12): 2777-92.

QASEEM A, FORCIEA M A, MCLEAN R M, et al. Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians [J]. Ann Intern Med, 2017, 166(11): 818-39.

REN L J, ZHU X H, TAN J T, et al. MiR-210 improves postmenopausal osteoporosis in ovariectomized rats through activating VEGF/Notch signaling pathway [J]. BMC Musculoskelet Disord, 2023, 24(1): 393.

MA T L, ZHU P, KE Z R, et al. Focusing on OB-OC-MΦ Axis and miR-23a to Explore the Pathogenesis and Treatment Strategy of Osteoporosis [J]. Front Endocrinol (Lausanne), 2022, 13: 891313.

YU T, YOU X, ZHOU H, et al. MiR-16-5p regulates postmenopausal osteoporosis by directly targeting VEGFA [J]. Aging (Albany NY), 2020, 12(10): 9500-14.

LEE K S, LEE J, KIM H K, et al. Extracellular vesicles from adipose tissue-derived stem cells alleviate osteoporosis through osteoprotegerin and miR-21-5p [J]. J Extracell Vesicles, 2021, 10(12): e12152.

FU Y, XU Y, CHEN S, et al. MiR-151a-3p Promotes Postmenopausal Osteoporosis by Targeting SOCS5 and Activating JAK2/STAT3 Signaling [J]. Rejuvenation Res, 2020, 23(4): 313-23.

WANG J, GAO Z, GAO P. MiR-133b Modulates the Osteoblast Differentiation to Prevent Osteoporosis Via Targeting GNB4 [J]. Biochem Genet, 2021, 59(5): 1146-57.

WANG W W, YANG L, WU J, et al. The function of miR-218 and miR-618 in postmenopausal osteoporosis [J]. Eur Rev Med Pharmacol Sci, 2017, 21(24): 5534-41.

LIU H P, HAO D J, WANG X D, et al. MiR-30a-3p promotes ovariectomy-induced osteoporosis in rats via targeting SFRP1 [J]. Eur Rev Med Pharmacol Sci, 2019, 23(22): 9754-60.

AN H, CHU C, ZHANG Z, et al. Hyperoside alleviates postmenopausal osteoporosis via regulating miR-19a-5p/IL-17A axis [J]. Am J Reprod Immunol, 2023, 90(1): e13709.

MA J, LIN X, CHEN C, et al. Circulating miR-181c-5p and miR-497-5p Are Potential Biomarkers for Prognosis and Diagnosis of Osteoporosis [J]. J Clin Endocrinol Metab, 2020, 105(5).

DING M, LIU B, CHEN X, et al. MiR-99b-5p suppressed proliferation of human osteoblasts by targeting FGFR3 in osteoporosis [J]. Hum Cell, 2021, 34(5): 1398-409.

YOU Y, LIU J, ZHANG L, et al. WTAP-mediated m(6)A modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis [J]. Cell Death Dis, 2023, 14(1): 33.

ZHANG X, ZHU Y, ZHANG C, et al. miR-542-3p prevents ovariectomy-induced osteoporosis in rats via targeting SFRP1 [J]. J Cell Physiol, 2018, 233(9): 6798-806.

LI L, ZHENG B, ZHANG F, et al. LINC00370 modulates miR-222-3p-RGS4 axis to protect against osteoporosis progression [J]. Arch Gerontol Geriatr, 2021, 97: 104505.

WANG Z, ZHANG H, LI Q, et al. Long non-coding RNA KCNQ1OT1 alleviates postmenopausal osteoporosis by modulating miR-421-3p/mTOR axis [J]. Sci Rep, 2023, 13(1): 2333.

ZHAO W, DONG Y, WU C, et al. MiR-21 overexpression improves osteoporosis by targeting RECK [J]. Mol Cell Biochem, 2015, 405(1-2): 125-33.

UMAR T, MA X, YIN B, et al. miR-424-5p overexpression inhibits LPS-stimulated inflammatory response in bovine endometrial epithelial cells by targeting IRAK2 [J]. J Reprod Immunol, 2022, 150: 103471.

WEI Y, MA H, ZHOU H, et al. miR-424-5p shuttled by bone marrow stem cells-derived exosomes attenuates osteogenesis via regulating WIF1-mediated Wnt/β-catenin axis [J]. Aging (Albany NY), 2021, 13(13): 17190-201.

LI M, YANG N, HAO L, et al. Melatonin Inhibits the Ferroptosis Pathway in Rat Bone Marrow Mesenchymal Stem Cells by Activating the PI3K/AKT/mTOR Signaling Axis to Attenuate Steroid-Induced Osteoporosis [J]. Oxid Med Cell Longev, 2022, 2022: 8223737.

LI S, CUI Y, LI M, et al. Acteoside Derived from Cistanche Improves Glucocorticoid-Induced Osteoporosis by Activating PI3K/AKT/mTOR Pathway [J]. J Invest Surg, 2023, 36(1): 2154578.

LI M, YANG N, HAO L, et al. Melatonin Inhibits the Ferroptosis Pathway in Rat Bone Marrow Mesenchymal Stem Cells by Activating the PI3K/AKT/mTOR Signaling Axis to Attenuate Steroid-Induced Osteoporosis [J]. Oxid Med Cell Longev, 2022, 2022: 8223737.

CANALIS E. Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches [J]. Nat Rev Endocrinol, 2013, 9(10): 575-83.

RACHNER T D, KHOSLA S, HOFBAUER L C. Osteoporosis: now and the future [J]. Lancet, 2011, 377(9773): 1276-87.

RONG X, KOU Y, ZHANG Y, et al. ED-71 Prevents Glucocorticoid-Induced Osteoporosis by Regulating Osteoblast Differentiation via Notch and Wnt/β-Catenin Pathways [J]. Drug Des Devel Ther, 2022, 16: 3929-46.

GAO Y, CHEN N, FU Z, et al. Progress of Wnt Signaling Pathway in Osteoporosis [J]. Biomolecules, 2023, 13(3).

MAEDA K, KOBAYASHI Y, KOIDE M, et al. The Regulation of Bone Metabolism and Disorders by Wnt Signaling [J]. Int J Mol Sci, 2019, 20(22).

YANG W, HAN W, QIN A, et al. The emerging role of Hippo signaling pathway in regulating osteoclast formation [J]. J Cell Physiol, 2018, 233(6): 4606-17.

XIAO L, ZHONG M, HUANG Y, et al. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-κB signaling pathways [J]. Aging (Albany NY), 2020, 12(21): 21706-29.

WANG L J, CAI H Q. Let-7b downgrades CCND1 to repress osteogenic proliferation and differentiation of MC3T3-E1 cells: An implication in osteoporosis [J]. Kaohsiung J Med Sci, 2020, 36(10): 775-85.

WANG J Z, ZHAO B H. MiR-23b-3p functions as a positive factor for osteoporosis progression by targeting CCND1 in MC3T3-E1 cells [J]. In Vitro Cell Dev Biol Anim, 2021, 57(3): 324-31.

LIN Z, ZHENG J, CHEN J, et al. Antiosteoporosis Effect and Possible Mechanisms of the Ingredients of Fructus Psoraleae in Animal Models of Osteoporosis: A Preclinical Systematic Review and Meta-Analysis [J]. Oxid Med Cell Longev, 2021, 2021: 2098820.

DUAN J, LI H, WANG C, et al. BMSC-derived extracellular vesicles promoted osteogenesis via Axin2 inhibition by delivering MiR-16-5p [J]. Int Immunopharmacol, 2023, 120: 110319.

WEN X, HU G, XIAO X, et al. FGF2 positively regulates osteoclastogenesis via activating the ERK-CREB pathway [J]. Arch Biochem Biophys, 2022, 727: 109348.